Delivery Order SPE2DB20D1100-SPE2DB25FY62D

Award Date 10/21/24
Potential Completion Date 10/22/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,158.44 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,510.07, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $1,008.39, is a delivery order for 4,564,389,901 units of the pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. The contract has no set-aside designation and is a firm fixed-price arrangement with an ultimate completion date of April 25, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
This is a federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award, valued at $1,118.63, is a Delivery Order contract with the Defense Logistics Agency (DLA) for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. Amerisourcebergen is a large pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.41 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a performance period ending on March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG nasal sprays. The $1,152.24 firm fixed-price contract has a completion date of November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of NAYZILAM 5 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $1,008.39 and an ultimate completion date of April 17, 2024. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $2,016.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NAYZILAM 5 MG NASAL SPRAYS to the U.S. government. The contract, valued at $1,344.52, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $1,674.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FY62D
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,344.52, is for the delivery of NAYZILAM 5 MG nasal sprays. It is a firm fixed-price delivery order contract with an ultimate completion date of October 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/26/25, 12:06 AM